DSMIG-USA - INTELLECTUAL AND DEVELOPMENTAL DISABILITY COVID-19 VACCINATION POSITION STATEMENT

August 13, 2021 DSAMD

DSMIG-USA - INTELLECTUAL AND DEVELOPMENTAL DISABILITY COVID-19 VACCINATION POSITION STATEMENT

Updated -May, 2021

SUMMARY

We agree with the CDC recommendations that the COVID-19 vaccines are appropriate and recommended for most people. The vaccine may not be appropriate for people with severe allergies.
People with Down syndrome, particularly those over 40 years of age and people less than 40 years of age with risk factors, are more susceptible to complications from COVID-19 infection.
These vaccines specifically and messenger RNA vaccines in general have not been studied in people with Down syndrome or other intellectual disabilities. This is often the case for other vaccines, medications, and supplements.
Since there is a lack of data regarding the benefits and risks of the COVID-19 vaccines for people with Down syndrome and other intellectual disabilities, this recommendation is based on the results of vaccine testing for people without Down syndrome or another intellectual disability. The disproportionate effect of the pandemic on this population was also considered.
Previous vaccines that also trigger the immune system (albeit with different technology) have not had significantly different side effects for people with Down syndrome or other intellectual disabilities.
Studies indicate the vaccine is a safe path to reduce symptomatic COVID-19, save lives, and aid in a more rapid return to the many aspects of our lives that have been altered.